Checkpoint Therapeutics Inc. held a virtual special meeting of stockholders on May 28, 2025, to vote on certain proposals related to the Agreement and Plan of Merger with Sun Pharmaceutical Industries, Inc., and Snoopy Merger Sub, Inc. The stockholders approved the Merger Proposal, which involved adopting the Merger Agreement. Additionally, the stockholders approved the Compensation Proposal on a non-binding, advisory basis.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.